Cargando…
Increased Central Auditory Gain and Decreased Parvalbumin-Positive Cortical Interneuron Density in the Df1/+ Mouse Model of Schizophrenia Correlate With Hearing Impairment
BACKGROUND: Hearing impairment is a risk factor for schizophrenia. Patients with 22q11.2 deletion syndrome have a 25% to 30% risk of schizophrenia, and up to 60% also have varying degrees of hearing impairment, primarily from middle-ear inflammation. The Df1/+ mouse model of 22q11.2 deletion syndrom...
Autores principales: | Zinnamon, Fhatarah A., Harrison, Freya G., Wenas, Sandra S., Liu, Qing, Wang, Kuan Hong, Linden, Jennifer F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382707/ https://www.ncbi.nlm.nih.gov/pubmed/37519460 http://dx.doi.org/10.1016/j.bpsgos.2022.03.007 |
Ejemplares similares
-
The Role of Parvalbumin-positive Interneurons in Auditory Steady-State Response Deficits in Schizophrenia
por: Metzner, Christoph, et al.
Publicado: (2019) -
Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism
por: Borkowska, Malgorzata, et al.
Publicado: (2016) -
Contrast gain control occurs independently of both parvalbumin-positive interneuron activity and shunting inhibition in auditory cortex
por: Cooke, James E., et al.
Publicado: (2020) -
Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia
por: Jiang, Zhihong, et al.
Publicado: (2013) -
Hearing Loss in a Mouse Model of 22q11.2 Deletion Syndrome
por: Fuchs, Jennifer C., et al.
Publicado: (2013)